Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Klaus Dr. Wirth is active.

Publication


Featured researches published by Klaus Dr. Wirth.


Archive | 1994

Use of Bradykinin-antagonists for the manufacture of a medicament for the prophylaxis and treatment of arteriosclerosis

Wolfgang Dr. Linz; Klaus Dr. Wirth; Bernward Prof. Dr. Schölkens; Gerhard Breipohl; Stephan Henke; Jochen Knolle


Archive | 1997

(Aminoalkyl- and acylaminoalkyl-oxy)benzyloxyquinolines, process for their preparation and use as Bradykinin receptor antagonists

Holger Heitsch; Adalbert Wagner; Klaus Dr. Wirth; Bernward Prof. Dr. Schölkens; Gerhard Nolken


Archive | 1993

Peptides with N-terminal modifications having bradykinin antagonistic activity

Gerhard Breipohl; Stephan Henke; Jochen Knolle; Bernward Prof. Dr. Schölkens; Hans-Georg Alpermann; Hermann Dr. Gerhards; Klaus Dr. Wirth


Archive | 1997

Use of non-peptide bradykinin antagonists for treating and preventing chronic fibrogenetic liver diseases, acute liver diseases and complications thereof

Holger Heitsch; Adalbert Wagner; Klaus Dr. Wirth; Max Hropot; Martin Bickel


Archive | 1997

Fluoralkyl- and fluoralkoxy-substituted heterocyclic bradykinin antagonists

Adalbert Wagner; Holger Heitsch; Gerhard Dr. Nölkne; Klaus Dr. Wirth; Bernard


Archive | 1997

Use of non-peptidic bradykinin antagonists in the preparation of medicaments for the treatment and prevention of Alzheimer's disease

Holger Heitsch; Gabriele Wiemer; Klaus Dr. Wirth


Archive | 1994

Use of bradykinin antagonists for the treatment of viral diseases

Fred Lembeck; Klaus Dr. Wirth; Irvin Winkler; Gerhard Breipohl; Stephan Henke; Jochen Knolle


Archive | 1996

New 1-(4-amino-benzyl)-pyrrolidine propionic acid derivatives

Adalert Dr Wagner; Gerhard Breipohl; Holger Heitsch; Hermann Dr. Gerhards; Gerhard Dr Noelken; Klaus Dr. Wirth; Bernward Prof Dr Schoelkens


Archive | 2004

Use of specific 2-substituted benzamides for treating and preventing cardiac insufficiency, especially where caused by diastolic dysfunction, act by inhibition of the Kv1.5 potassium channel

Klaus Dr. Wirth


Archive | 2004

Substituted 2 amino imidazoles, method for their manufacture and their use as a drug or diagnostic and drug containing them

Uwe Heinelt; Jochen-Hans Dr. Lang; Armin Hofmeister; Klaus Dr. Wirth; Hans-Willi Jansen

Collaboration


Dive into the Klaus Dr. Wirth's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Uwe Heinelt

Case Western Reserve University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge